Financhill
Back

4D Molecular Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Buy
51

FDMT
4D Molecular Therapeutics

Last Price:
6.90
Seasonality Move:
19.19%
Sell
23

NBY
NovaBay Pharmaceuticals

Last Price:
0.54
Seasonality Move:
-8.54%
Buy
51
4D Molecular Therapeutics (FDMT) is a Buy

Is 4D Molecular Therapeutics a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics [FDMT] share price is $7.24. The Score for FDMT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • FDMT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.59. The Score for NBY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics's stock price today?

  • The 4D Molecular Therapeutics share price today is $7.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 40.08 Sell
Chaikin Money Flow: 216927 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.33 - 8.35) Sell
Bollinger Bands (100): (8.1 - 15.48) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 40.07 Sell
Chaikin Money Flow: 8462 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.6 - 0.72) Sell
Bollinger Bands (100): (0.34 - 1) Sell

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.28 Sell
20-day SMA: 7.74 Sell
50-day SMA: 8.39 Sell
200-day SMA: 18.93 Sell
8-day EMA: 7.31 Sell
20-day EMA: 7.67 Sell
50-day EMA: 9.04 Sell
200-day EMA: 15.11 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.59 Buy
20-day SMA: 0.65 Sell
50-day SMA: 0.66 Sell
200-day SMA: 2.07 Sell
8-day EMA: 0.59 Sell
20-day EMA: 0.63 Sell
50-day EMA: 0.68 Sell
200-day EMA: 5.05 Sell

4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.69 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

4D Molecular Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):